Literature DB >> 7989442

MTT colorimetric assay system for the screening of anti-orthomyxo- and anti-paramyxoviral agents.

W Watanabe1, K Konno, K Ijichi, H Inoue, T Yokota, S Shigeta.   

Abstract

A rapid and sensitive method was developed for screening potential antiviral agents against orthomyxo- and paramyxoviruses, using the MTT method with cell culture suspensions. The cell lines used for the assay were as follows: MDCK cells for the influenza A virus (Fluv. A), HeLa cells for the respiratory syncytial virus (RSV), and Vero cells for the measles virus (MSV). Test compounds were diluted and plated in 96-well round-bottomed microtiter plates. Trypsinized cell suspensions and viruses were added to each well, the plates were then centrifuged (700 x g, 5 min, room temperature), and incubated for several days. The MTT assay was carried out after the degeneration of virus-infected cells became evident. The optical density (OD) of formazan was determined using a computer-controlled microplate reader. With this assay system, the EC50 values of Ribavirin (used as the reference compound) were 3.7 micrograms/ml for Fluv. A, 4.5 micrograms/ml for RSV, and 12.3 micrograms/ml for MSV, respectively. These EC50 values were equivalent to those obtained using the plaque reduction assay. The confluent cell culture system was inadequate for antiviral assays against RSV and MSV when the MTT method was used, because the inhibition of formazan formation was not observed in viral-infected cells. Moreover, the suspension method is more sensitive to the cytotoxicity of antiviral agents than the confluent cell culture system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989442     DOI: 10.1016/0166-0934(94)90124-4

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  16 in total

1.  Patchouli alcohol: in vitro direct anti-influenza virus sesquiterpene in Pogostemon cablin Benth.

Authors:  Hiroaki Kiyohara; Chikara Ichino; Yuka Kawamura; Takayuki Nagai; Noriko Sato; Haruki Yamada
Journal:  J Nat Med       Date:  2011-06-14       Impact factor: 2.343

2.  Cyclic dipeptides from lactic acid bacteria inhibit proliferation of the influenza A virus.

Authors:  Min-Kyu Kwak; Rui Liu; Jun-Oh Kwon; Min-Kyu Kim; Andrew HyoungJin Kim; Sa-Ouk Kang
Journal:  J Microbiol       Date:  2013-12-19       Impact factor: 3.422

3.  Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors.

Authors:  A Sauerbrei; A Haertl; A Brandstaedt; M Schmidtke; P Wutzler
Journal:  Med Microbiol Immunol       Date:  2005-07-30       Impact factor: 3.402

4.  Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen.

Authors:  Simon J F Macdonald; Keith G Watson; Rachel Cameron; David K Chalmers; Derek A Demaine; Rob J Fenton; David Gower; J Nicole Hamblin; Stephanie Hamilton; Graham J Hart; Graham G A Inglis; Betty Jin; Haydn T Jones; Darryl B McConnell; Andy M Mason; Van Nguyen; Ian J Owens; Nigel Parry; Phillip A Reece; Stephen E Shanahan; Donna Smith; Wen-Yang Wu; Simon P Tucker
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

5.  A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays.

Authors:  Jason P Roth; Joseph K-K Li; Donald F Smee; John D Morrey; Dale L Barnard
Journal:  Antiviral Res       Date:  2009-02-02       Impact factor: 5.970

6.  A colorimetric-based accurate method for the determination of enterovirus 71 titer.

Authors:  Hamid Reza Pourianfar; Arman Javadi; Lara Grollo
Journal:  Indian J Virol       Date:  2012-09-19

7.  Antiviral activity of diarylheptanoid stereoisomers against respiratory syncytial virus in vitro and in vivo.

Authors:  Katsuhiko Konno; Motofumi Miura; Masaharu Toriyama; Shigeyasu Motohashi; Rie Sawamura; Wataru Watanabe; Hiroki Yoshida; Masahiko Kato; Ryuichi Yamamoto; Ken Yasukawa; Masahiko Kurokawa
Journal:  J Nat Med       Date:  2013-01-24       Impact factor: 2.343

8.  Antiviral activities of diarylheptanoids against influenza virus in vitro.

Authors:  Rie Sawamura; Yi Sun; Ken Yasukawa; Tomomi Shimizu; Wataru Watanabe; Masahiko Kurokawa
Journal:  J Nat Med       Date:  2009-11-07       Impact factor: 2.343

9.  Nano-NRTIs demonstrate low neurotoxicity and high antiviral activity against HIV infection in the brain.

Authors:  Trevor Gerson; Edward Makarov; Thulani H Senanayake; Santhi Gorantla; Larisa Y Poluektova; Serguei V Vinogradov
Journal:  Nanomedicine       Date:  2013-07-09       Impact factor: 5.307

10.  In vivo anti-influenza virus activity of Japanese herbal (kampo) medicine, "shahakusan," and its possible mode of action.

Authors:  Rei Hokari; Takayuki Nagai; Haruki Yamada
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.